Search Prime Grants

K01CA276624

Project Grant

Overview

Grant Description
A technology-enhanced and multilevel approach to promote cervical cancer prevention among women living with HIV.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Washington, District Of Columbia 200063434 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 100% from $172,638 to $345,276.
George Washington University (The) was awarded Project Grant K01CA276624 worth $345,276 from National Cancer Institute in September 2023 with work to be completed primarily in Washington District Of Columbia United States. The grant has a duration of 5 years and was awarded through assistance program 93.398 Cancer Research Manpower. The Project Grant was awarded through grant opportunity NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required).

Status
(Ongoing)

Last Modified 9/20/24

Period of Performance
9/15/23
Start Date
8/31/28
End Date
34.0% Complete

Funding Split
$345.3K
Federal Obligation
$0.0
Non-Federal Obligation
$345.3K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to K01CA276624

Transaction History

Modifications to K01CA276624

Additional Detail

Award ID FAIN
K01CA276624
SAI Number
K01CA276624-3304189751
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
ECR5E2LU5BL6
Awardee CAGE
4L405
Performance District
DC-98

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $172,638 100%
Modified: 9/20/24